Want to join the conversation?
Pharma companies $REGN and Sanofi said they finished enrollment in global Phase 3 Odyssey outcomes trial, which evaluates potential cardiovascular benefits of Praluent Injection after an acute coronary syndrome. The 18,000-patient trial is expected to be completed in 2017.
$NFLX a monster move, going up. Expect making some money on Monday.
$AMD down more than 6% even after posting above consensus third quarter results.
$MCD stock rose more than 2% after it posted better than expected 3Q16 results, driven by global same-store sales growth. Meanwhile, earnings and revenue were lower than last year, hurt by refranchising efforts.
$RAI has received a $47 billion take over offer from British tobacco giant British American Tobacco! This is huge!